Silodosin a new alpha1 A-adrenoceptor-selective antagonist for treating benign prostatic hyperplasia: results of a phase III randomized, placebo-controlled, double-blind study in Japanese men - Kawabe, K; Yoshida, M; Homma, Y (BJU Int, 2006)